miR-210 as a therapeutic target in diabetes-associated endothelial dysfunction.
Collado A, Jiao T, Kontidou E, Carvalho LRRA, Chernogubova E, Yang J, Zaccagnini G, Zhao A, Tengbom J, Zheng X, Rethi B, Alvarsson M, Catrina SB, Mahdi A, Carlström M, Martelli F, Pernow J, Zhou Z.
Collado A, et al. Among authors: mahdi a.
Br J Pharmacol. 2024 Oct 14. doi: 10.1111/bph.17329. Online ahead of print.
Br J Pharmacol. 2024.
PMID: 39402703